<DOC>
	<DOCNO>NCT00637078</DOCNO>
	<brief_summary>The objective study assess implementation treatment algorithm include initial treatment low dose diuretic/ACE-inhibitor ARB combination subsequently low dose DHP-CCB/statin combination improve management hypertension/hypercholesterolemia compare guidelines-base management family practice .</brief_summary>
	<brief_title>STITCH2 ( Simplified Therapeutic Intervention Control Hypertension Hypercholesterolemia )</brief_title>
	<detailed_description>Utilization fix dose combination therapy advocate adherence-enhancing strategy recommend 2007 Canadian Hypertension Education Program ( CHEP ) recommendation . Further , previous study ( STITCH ) demonstrate simplified treatment algorithm utilize initial therapy low dose fixed-dose combination therapy improve blood pressure control hypertensive patient . However , effectiveness either simplify treatment algorithm initial use fix dose combination therapy 2 risk factor hypertensive dyslipidemic patient yet determine . Therefore , current study design determine whether utilization fix dose combination hypertension/hypercholesterolemia therapy result improve adherence , patient satisfaction well improve rate reach target LDL cholesterol blood pressure .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>male female subject 18 year older document diagnosis hypertension hypercholesterolemia current therapy condition uncontrolled hypertension ( SBP &gt; 140 mmHg DBP &gt; 90 mmHg ) cholesterol level threshold base global atherosclerotic risk profile ( base ATP III assessment ) ability give write informed consent ischemic heart disease , atrial fibrillation , chronic kidney disease significant liver disease currently prescribe 3 drug control blood pressure currently prescribe 2 drug control hypercholesterolemia participate hypertension/hypercholesterolemia study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>family physician</keyword>
	<keyword>fix dose combination therapy</keyword>
	<keyword>cluster randomize control trial</keyword>
</DOC>